Our study reported the first case of APLAID with gangrenous pyoderma and concomitant high IgE carrying a novel PLCG2 mutation, which may expand the clinical phenotype and genotype of APLAID. The gene discussed is IGHE; the disease is autoinflammation-PLCG2-associated antibody deficiency-immune dysregulation.